Revvity RVTY Life Sciences — Foreign currency translation
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Revvity in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revvity's life sciences — foreign currency translation.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revvity's life sciences — foreign currency translation?
- Revvity (RVTY) reported life sciences — foreign currency translation of -$24.95M in Q1 2026.
- How has Revvity's life sciences — foreign currency translation changed year-over-year?
- Revvity's life sciences — foreign currency translation decreased by 174.2% year-over-year, from $33.63M to -$24.95M.
- What is the long-term trend for Revvity's life sciences — foreign currency translation?
- Over 3 years (2022 to 2025), Revvity's life sciences — foreign currency translation has grown at a 5.6% compound annual growth rate (CAGR), from -$98.27M to $115.58M.
- What does life sciences — foreign currency translation mean?
- The financial impact of changing currency exchange rates on the Life Sciences segment's performance.
- How do you interpret life sciences — foreign currency translation?
- Positive values indicate a favorable currency tailwind, while negative values indicate a headwind that suppresses reported growth.
- How does life sciences — foreign currency translation compare across companies?
- Standard disclosure for multinational companies with significant non-domestic revenue streams.